Yulin Li

Dr. Yulin Li


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Closed access
PDF file
YCYanan Cao
Yanan Cao
BFBiao Feng
Biao Feng
SCShali Chen
Shali Chen
YLYulin Li
Yulin Li
Subrata ChakrabartiSubrata Chakrabarti
Subrata Chakrabarti
Purpose.: Hyperglycemia-induced endothelial damage is a key pathogenetic factor in diabetic retinopathy. Endothelial damage may lead to phenotypic changes in the cells manifested by reduced expression of endothelial markers and increased expression of mesenchymal markers, termed endothelial to mesenchymal transition (EndMT). We investigated mechanisms of such changes in the retinal endothelial cells and in the retina of diabetic animals. Methods.: Human retinal microvascular endothelial cells were grown in medium containing 5 mM glucose or 25 mM glucose with or without TGFβ1 peptide or TGFβ1 inhibitor or miR-200b mimic transfection. Messenger RNA levels of endothelial markers, mesenchymal markers, and specific signaling molecules of TGFβ pathway were quantified. Expression of miR-200b and histone acetylator p300 was quantified. Retinal tissues from mice with endothelial-specific overexpression of miR-200b, with or without streptozotocin-induced diabetes, were similarly examined. Results.: Glucose caused decreased expression of mRNA and protein levels of endothelial markers and increased expression of mesenchymal markers with reduced miR-200b. A glucose-like effect was seen using TGFβ1 peptide. Such changes were mediated by miR-200b and p300. In the retinas of wild-type diabetic mice, EndMT was observed, which was prevented in miR-200b transgenic mice with diabetes. Conclusions.: These data indicate glucose-induced EndMT in vitro and in vivo is possibly mediated through TGFβ and regulated by miR-200b and p300.

12 October 2023 in Molecular Medicine
Verified
Journal Article
Open access
PDF file
CYCan Yang
Can Yang
ZZZhen Zhang
Zhen Zhang
JLJieting Liu
Jieting Liu
PCPeijian Chen
Peijian Chen
JLJialing Li
Jialing Li
LLLuxin Li
Luxin Li
Diabetic kidney disease (DKD) is the main cause of end-stage renal disease, and its clinical manifestations are progressive proteinuria, decreased glomerular filtration rate, and renal failure. The injury and death of glomerular podocytes are the keys to DKD. Currently, a variety of cell death modes have been identified in podocytes, including apoptosis, autophagy, endoplasmic reticulum (ER) stress, pyroptosis, necroptosis, ferroptosis, mitotic catastrophe, etc. The signaling pathways leading to these cell death processes are interconnected and can be activated simultaneously or in parallel. They are essential for cell survival and death that determine the fate of cells. With the deepening of the research on the mechanism of cell death, more and more researchers have devoted their attention to the underlying pathologic research and the drug therapy research of DKD. In this paper, we discussed the podocyte physiologic role and DKD processes. We also provide an overview of the types and specific mechanisms involved in each type of cell death in DKD, as well as related targeted therapy methods and drugs are reviewed. In the last part we discuss the complexity and potential crosstalk between various modes of cell death, which will help improve the understanding of podocyte death and lay a foundation for new and ideal targeted therapy strategies for DKD treatment in the future.

10 March 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
DKDan Ke
Dan Ke
ZZZhen Zhang
Zhen Zhang
JLJieting Liu
Jieting Liu
PCPeijian Chen
Peijian Chen
JLJialing Li
Jialing Li
LLLuxin Li
Luxin Li
Diabetes is a common chronic metabolic disease, and its incidence continues to increase year after year. Diabetic patients mainly die from various complications, with the most common being diabetic cardiomyopathy. However, the detection rate of diabetic cardiomyopathy is low in clinical practice, and targeted treatment is lacking. Recently, a large number of studies have confirmed that myocardial cell death in diabetic cardiomyopathy involves pyroptosis, apoptosis, necrosis, ferroptosis, necroptosis, cuproptosis, cellular burial, and other processes. Most importantly, numerous animal studies have shown that the onset and progression of diabetic cardiomyopathy can be mitigated by inhibiting these regulatory cell death processes, such as by utilizing inhibitors, chelators, or genetic manipulation. Therefore, we review the role of ferroptosis, necroptosis, and cuproptosis, three novel forms of cell death in diabetic cardiomyopathy, searching for possible targets, and analyzing the corresponding therapeutic approaches to these targets.

5 February 2020 in Physiological Reports
Verified
Journal Article
Open access
PDF file
JLJieting Liu
Jieting Liu
SCShali Chen
Shali Chen
SBSaumik Biswas
Saumik Biswas
NNNiharika Nagrani
Niharika Nagrani
YLYulin Li
Yulin Li
BFBiao Feng
Biao Feng
We examined the role of mitochondrial sirtuins (SIRTs) in glucose‐induced oxidative stress, EC senescence and their regulation by miRNAs by using RT‐qPCR, ELISA, Western blot, senescence‐associated β...

1 January 2016 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
HLHaifeng Liu
Haifeng Liu
XWXiaohua Wang
Xiaohua Wang
SLShengfeng Liu
Shengfeng Liu
HLHongzhi Li
Hongzhi Li
Xiaohuan YuanXiaohuan Yuan
Xiaohuan Yuan
HLHongjian Li
Hongjian Li

1 April 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Xiaohuan YuanXiaohuan Yuan
Xiaohuan Yuan
HLHongzhi Li
Hongzhi Li
HBHe Bai
He Bai
ZSZhijian Su
Zhijian Su
QXQi Xiang
Qi Xiang
YHYahuang Huang
Yahuang Huang